Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers. Current customers who pay for the drugs out of pocket — without the help of health insurance — will now be charged $349 per month, down from $499, the Danish drugmaker said Monday. Novo Nordisk…
President Donald Trump has announced a landmark deal aiming to expand Medicare coverage to include certain weight-loss medications, a move that could dramatically change access to these treatments for millions of older Americans. On November 6, Trump revealed that his administration had struck agreements with Eli Lilly and Novo Nordisk, the makers of popular weight-loss…
(Reuters) -Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss drugs at $149 per month, in exchange for Medicare coverage, Endpoints News reported on Tuesday, citing sources familiar with the matter. Patients in the U.S. currently pay the most for prescription medicines,…
By Arasu Kannagi Basil (Reuters) -MapLight Therapeutics debuted on the Nasdaq on Monday with a valuation of $787 million, becoming the first company to go public under a rarely used regulatory provision since the start of the U.S. government shutdown. Shares of the Redwood City, California-based company, which is developing treatments for central nervous system…
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments introduced significant uncertainty regarding the future pricing of the company’s weight-loss and diabetes drugs, Zepbound and Mounjaro. The drop occurred after President Donald Trump suggested that the price for the GLP-1 drug category, which Eli Lilly dominates alongside…
NEW YORK (AP) — Armed with hundreds of thousands of dollars from Newman’s Own Foundation and Ozempic creator Novo Nordisk, young Native Americans are leading the fight against persistently high rates of food insecurity in tribal communities. In a rare example of agency for a beneficiary community, 21 emerging Indigenous leaders recently crafted selection criteria,…
Costco to sell weight loss drugs Costco now selling weight loss drugs Ozempic, Wegovy at a discount 03:19 Costco customers can now buy Ozempic and Wegovy at the discount chain’s drugstores. Novo Nordisk, the Danish pharmaceutical firm that makes the weight-loss drugs, announced Friday that Ozempic and Wegovy are available at Costco pharmacies across the…
If you’re holding Novo Nordisk stock or considering jumping in, you’ve probably watched its recent moves with more than a little curiosity. Novo Nordisk may not be a household name on every street, but within the investing world it turns heads, thanks to a long-term run that’s seen plenty of growth balanced by some eye-catching…
By Andrew Silver SHANGHAI (Reuters) -Innovent Biologics’ newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals as it pursues a marketing strategy that is gaining traction. Xinermei, launched in July, is the third once-weekly injectable GLP-1 weight management therapy available in China after Novo…
Novo Nordisk A/S (NYSE:NVO) presented data from the STEER real-world study of evidence gathered from actual patient experiences at the European Society of Cardiology (ESC) Congress 2025. The STEER study investigated the risk of major adverse cardiovascular events (MACE) with Wegovy (semaglutide) 2.4 mg compared with Eli Lilly and Co.’s (NYSE:LLY) tirzepatide treatment in people with…